The development, maturation, and maintenance of the inner ear are governed by temporal and spatial expression cascades of transcription factors that form a gene regulatory network. ISLET1 (ISL1) may be one of the major players in this cascade, and in order to study its role in the regulation of inner ear development, we produced a transgenic mouse overexpressing Isl1 under the Pax2 promoter. Pax2-regulated ISL1 overexpression increases the embryonic ISL1(+) domain and induces accelerated nerve fiber extension and branching in E12.5 embryos. Despite these gains in early development, the overexpression of ISL1 impairs the maintenance and function of hair cells of the organ of Corti. Mutant mice exhibit hyperactivity, circling behavior, and progressive age-related decline in hearing functions, which is reflected in reduced otoacoustic emissions (DPOAEs) followed by elevated hearing thresholds. The reduction of the amplitude of DPOAEs in transgenic mice was first detected at 1 month of age. By 6-9 months of age, DPOAEs completely disappeared, suggesting a functional inefficiency of outer hair cells (OHCs). The timing of DPOAE reduction coincides with the onset of the deterioration of cochlear efferent terminals. In contrast to these effects on efferents, we only found a moderate loss of OHCs and spiral ganglion neurons. For the first time, our results show that the genetic alteration of the medial olivocochlear (MOC) efferent system induces an early onset of age-related hearing loss. Thus, the neurodegeneration of the MOC system could be a contributing factor to the pathology of age-related hearing loss.

Department of Biology University of Iowa Iowa City IA 52242 USA

Institute of Experimental Medicine CAS Prague Czechia

Laboratory of Molecular Pathogenetics Institute of Biotechnology CAS Prague 4 CZ 142 20 Prague Czechia

Zobrazit více v PubMed

J Microsc. 2006 Dec;224(Pt 3):213-32 PubMed

Arch Otolaryngol. 1964 Oct;80:369-82 PubMed

J Neurosci Res. 2001 Feb 1;63(3):252-6 PubMed

Nature. 2005 Apr 21;434(7036):1031-5 PubMed

Hear Res. 2007 Dec;234(1-2):59-72 PubMed

Dev Biol. 2006 Jul 15;295(2):756-63 PubMed

EMBO J. 2008 Jul 23;27(14):2018-29 PubMed

Hear Res. 1999 Apr;130(1-2):94-107 PubMed

Hear Res. 2013 Mar;297:30-41 PubMed

Trends Genet. 2000 Feb;16(2):75-83 PubMed

J Neurosci. 2013 Jan 23;33(4):1564-76 PubMed

Cell. 1996 Jan 26;84(2):309-20 PubMed

Hear Res. 1997 Jun;108(1-2):74-82 PubMed

J Neurophysiol. 1987 Apr;57(4):1002-21 PubMed

Dev Dyn. 2008 Nov;237(11):3305-12 PubMed

J Appl Physiol (1985). 2010 Oct;109 (4):1195-202 PubMed

BMC Dev Biol. 2010 Aug 20;10 :89 PubMed

J Neurosci. 2014 Jul 23;34(30):10072-7 PubMed

J Neurosci. 2002 Dec 15;22(24):10838-46 PubMed

Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13870-5 PubMed

Development. 2004 Oct;131(20):5091-102 PubMed

J Comp Neurol. 2004 Sep 6;477(1):1-10 PubMed

Biophys J. 2010 Jun 16;98(12):2813-21 PubMed

Hear Res. 2012 Aug;290(1-2):13-20 PubMed

Brain Res Dev Brain Res. 1999 Oct 20;117(1):99-108 PubMed

FASEB J. 2003 Jul;17(10):1349-51 PubMed

Nat Rev Neurosci. 2006 Nov;7(11):837-49 PubMed

Cell Tissue Res. 2015 Jul;361(1):7-24 PubMed

Cell Tissue Res. 2015 Jan;359(1):315-32 PubMed

Dev Cell. 2003 Dec;5(6):877-89 PubMed

J Neurosci. 2006 Jan 11;26(2):550-8 PubMed

Nature. 2002 Sep 19;419(6904):300-4 PubMed

J Comp Neurol. 2004 Sep 27;477(4):412-21 PubMed

Nat Commun. 2013;4:1786 PubMed

Neuron. 2008 May 8;58(3):333-9 PubMed

Nature. 2005 Feb 24;433(7028):880-3 PubMed

Physiol Rev. 2009 Jan;89(1):1-26 PubMed

J Assoc Res Otolaryngol. 2011 Jun;12(3):329-43 PubMed

PLoS One. 2013;8(2):e56520 PubMed

Nucleic Acids Res. 2001 May 1;29(9):e45 PubMed

Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9697-702 PubMed

PLoS One. 2013 Dec 20;8(12):e82602 PubMed

Hear Res. 1999 Dec;138(1-2):65-72 PubMed

Dev Biol. 2010 Sep 15;345(2):180-90 PubMed

J Neurosci. 2014 Mar 26;34(13):4599-607 PubMed

J Comp Neurol. 2003 Jan 13;455(3):406-16 PubMed

Hear Res. 1997 Oct;112(1-2):199-215 PubMed

J Assoc Res Otolaryngol. 2000 Sep;1(2):129-43 PubMed

Hear Res. 1997 Feb;104(1-2):101-11 PubMed

Hear Res. 1996 Oct;100(1-2):101-6 PubMed

Nat Neurosci. 2005 Feb;8(2):149-55 PubMed

J Assoc Res Otolaryngol. 2011 Dec;12(6):711-7 PubMed

. 1995 Jan 1;1(4):385-400 PubMed

Dev Dyn. 2005 Nov;234(3):633-50 PubMed

Genesis. 2011 Apr;49(4):326-41 PubMed

J Neurophysiol. 1991 Jan;65(1):123-32 PubMed

Hear Res. 1996 Jul;96(1-2):71-82 PubMed

Neurobiol Aging. 2006 Mar;27(3):490-500 PubMed

Brain Res Bull. 2003 Jun 15;60(5-6):423-33 PubMed

J Neurosci Methods. 1990 Aug;33(2-3):129-33 PubMed

J Neurosci. 2013 Aug 28;33(35):14001-16 PubMed

J Neurophysiol. 1993 Dec;70(6):2519-32 PubMed

Cell Tissue Res. 2008 Dec;334(3):339-58 PubMed

Mol Cell Neurosci. 2011 Jul;47(3):215-22 PubMed

PLoS One. 2009 Nov 20;4(11):e7923 PubMed

Bioessays. 2006 Dec;28(12):1181-93 PubMed

J Neurosci. 2007 Nov 14;27(46):12707-20 PubMed

Hear Res. 2013 Mar;297:3-12 PubMed

Nat Neurosci. 2008 Nov;11(11):1283-93 PubMed

Dev Dyn. 2004 Dec;231(4):801-14 PubMed

ISL1 is necessary for auditory neuron development and contributes toward tonotopic organization

Overexpression of Isl1 under the Pax2 Promoter, Leads to Impaired Sound Processing and Increased Inhibition in the Inferior Colliculus

Molecular Aspects of the Development and Function of Auditory Neurons

Early ear neuronal development, but not olfactory or lens development, can proceed without SOX2

Neurod1 Is Essential for the Primary Tonotopic Organization and Related Auditory Information Processing in the Midbrain

Pax2-Islet1 Transgenic Mice Are Hyperactive and Have Altered Cerebellar Foliation

Incomplete and delayed Sox2 deletion defines residual ear neurosensory development and maintenance